Burning Rock Dx

About Burning Rock Dx

Burning Rock Biotech Limited (NASDAQ: BNR ) Burning Rock Biotech is a global diagnostics company specializing in next-generation sequencing (NGS) technology for precision oncology. Our Mission Guard Life via Science Our Vision To Become a New Pillar in the International Healthcare Industry What We Offer We provide solutions throughout the precision oncology development cycle, including: NGS-Based Assays: Comprehensive portfolio for tissue and blood samples In-House Database: Facilitating clinical trial studies and research Pharmaceutical Partner Services: Genomic data solutions Clinical trial solutions Precision patient recruitment Companion diagnostics (CDx) development and commercialization Global Operations With CLIA/CAP laboratories in China and the United States, we support global clinical trials. Our achievements include: 2 NMPA-Approved IVD Kits 4 Assays with CE Marking 1 MHLW-Approved CDx System Breakthrough Device Designation (BDD) from both the US FDA and China NMPA for multi-cancer detection blood tests Leveraging advanced NGS technology and extensive pharmaceutical partnerships, Burning Rock is dedicated to advancing precision oncology worldwide.